H Joachim Deeg Selected Research

Residual Neoplasm

2/2015

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Joachim Deeg Research Topics

Disease

76	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 01/2002
42	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2002
26	Neoplasms (Cancer) 01/2022 - 07/2002
25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022 - 01/2002
21	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 08/2002
16	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 07/2005
12	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 05/2005
10	Leukemia 12/2020 - 10/2003
8	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2020 - 09/2005
8	Bronchiolitis Obliterans Syndrome 01/2020 - 07/2002
6	Iron Overload 01/2016 - 11/2008
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 08/2004
5	Essential Thrombocythemia 11/2015 - 07/2002
5	Polycythemia Vera 11/2015 - 07/2002
5	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2006 - 08/2002
4	Anemia 01/2017 - 01/2008
4	Refractory Anemia with Excess of Blasts (RAEM) 01/2008 - 11/2004
3	Renal Insufficiency (Renal Failure) 01/2020 - 10/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012 - 03/2011
3	Necrosis 06/2010 - 07/2002
2	Cytopenia 12/2016 - 03/2010
2	Systemic Mastocytosis 01/2016 - 10/2014
2	Bone Marrow Failure Disorders 10/2015 - 09/2004
2	Fanconi Anemia (Fanconi's Anemia) 10/2015 - 09/2004
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2010 - 08/2003
2	Basal Cell Carcinoma (Rodent Ulcer) 02/2009 - 03/2006
2	Liver Failure 08/2008 - 03/2004
2	Fibrosis (Cirrhosis) 03/2007 - 01/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2006 - 05/2005
2	Refractory Anemia 12/2005 - 11/2004
1	Blast Crisis (Blast Phase) 11/2020
1	Jaundice (Icterus) 01/2020
1	Viremia 01/2020
1	Infections 01/2020
1	Bacteremia 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Disease Progression 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Hypoxia (Hypoxemia) 09/2015
1	Residual Neoplasm 02/2015

Drug/Important Bio-Agent (IBA)

10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2002
9	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 07/2002
7	Busulfan (Busulfex)FDA Link 01/2021 - 01/2002
7	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2017 - 11/2004
7	Methotrexate (Mexate)FDA LinkGeneric 12/2014 - 08/2003
6	Azacitidine (5 Azacytidine)FDA Link 12/2022 - 03/2010
6	fludarabineIBA 01/2018 - 12/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 09/2004
5	Lenalidomide (CC 5013)FDA Link 01/2017 - 01/2008
5	SteroidsIBA 01/2016 - 01/2002
5	GlucocorticoidsIBA 01/2014 - 04/2002
4	Prednisone (Sone)FDA LinkGeneric 01/2020 - 07/2002
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 05/2003
4	Proteins (Proteins, Gene)FDA Link 05/2015 - 12/2005
4	AntigensIBA 09/2012 - 09/2005
4	IronIBA 01/2011 - 02/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2009
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 07/2005
3	treosulfanIBA 01/2020 - 03/2011
3	Calcineurin InhibitorsIBA 01/2019 - 05/2008
3	thymoglobulin FDA Link 01/2017 - 05/2006
3	Tacrolimus (Prograf)FDA LinkGeneric 12/2014 - 05/2008
3	Etanercept (Enbrel)FDA Link 06/2010 - 11/2004
2	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2008
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2014
2	Histones (Histone)IBA 01/2014 - 01/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010 - 02/2010
2	Ferritins (Ferritin)IBA 10/2009 - 11/2008
2	LigandsIBA 01/2009 - 08/2003
2	TNF-Related Apoptosis-Inducing LigandIBA 12/2008 - 09/2004
2	Transferrin (beta 2 Transferrin)IBA 08/2008 - 03/2004
2	Caspase 8 (Caspase-8)IBA 09/2004 - 08/2003
1	eprenetapoptIBA 12/2022
1	Biological FactorsIBA 01/2022
1	H3B-8800IBA 12/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2021
1	trans-crotonin (CTN)IBA 01/2021
1	ruxolitinibIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	CytosineIBA 01/2017
1	CateninsIBA 01/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 12/2016
1	Janus KinasesIBA 11/2015
1	HLA-A Antigens (HLA-A)IBA 09/2015

Therapy/Procedure

89	Cell Transplantation 01/2022 - 05/2003
50	Therapeutics 01/2022 - 01/2002
42	Transplantation 12/2020 - 01/2002
20	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2002
8	Stem Cell Transplantation 05/2015 - 07/2002
7	Homologous Transplantation 01/2021 - 07/2005
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 03/2002
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 10/2003
3	Drug Therapy (Chemotherapy) 02/2015 - 12/2007
2	Aftercare (After-Treatment) 09/2017 - 03/2011
2	Erythrocyte Transfusion 10/2009 - 11/2008
2	Radiotherapy 02/2009 - 12/2007
1	Salvage Therapy 01/2016
1	Consolidation Chemotherapy 02/2015